ACMR ACM Research, Inc. - Fundamental Analysis
BEARISH
Sign in to save
Save this symbol to a watchlist or track a position.
ACMR Stock | Fundamental Analysis & Investment Insights
NASDAQ
Technology
Semiconductor Equipment & Materials
Current Price
Live
$64.84
Analyst Target
$46.45
-28.4%
Downside
52W High
$71.65
52W Low
$16.82
At a glance
Key valuation, profitability, growth, and risk metrics.
Updated Feb 14, 2026
Market cap
$4.21B
P/E
37.26
ROE
9.9%
Profit margin
13.3%
Debt/Equity
0.16
Dividend yield
N/A
AI Analysis
Powered by advanced machine learning algorithms
Confidence Score
85%
Analysis Accuracy
ACMR exhibits strong deterministic health with a Piotroski F-Score of 7/9, indicating solid operational efficiency and financial stability, though the absence of an Altman Z-Score raises concern about bankruptcy risk. The stock trades at a premium to both its Graham Number ($29.40) and intrinsic value estimate ($47.94), reflecting high growth expectations. However, recent insider selling totaling $17.65M over six months, combined with deteriorating earnings trends—most recently a -42.9% YoY EPS decline and a -18.2% Q/Q EPS drop—undermine confidence. Analysts' target price of $46.45 is below the current $64.84, signaling downside risk. Despite robust revenue growth (32% YoY), profitability and earnings momentum are weakening.
Key Strengths
Piotroski F-Score of 7/9 indicates strong financial health and operational efficiency
High gross margin (46.68%) and solid revenue growth (32% YoY) reflect competitive positioning in semiconductor equipment
Strong liquidity with current ratio of 3.48 and quick ratio of 2.44, indicating low short-term risk
Low debt/equity ratio (0.16) suggests conservative capital structure and minimal leverage risk
Historical track record of significant earnings surprises (e.g., +246.2% in 2023 Q1) shows potential for upside volatility
Key Risks
Insider selling activity (9 transactions, $17.65M) signals potential loss of confidence among executives
Recent earnings deterioration: -42.9% YoY EPS growth and -18.2% Q/Q EPS decline despite strong revenue growth
Current price ($64.84) significantly exceeds both Graham Number ($29.40) and intrinsic value ($47.94), implying overvaluation
Analyst target price ($46.45) is below current market price, indicating bearish consensus
No dividend and zero payout ratio reflect lack of shareholder return, limiting appeal to income investors
AI Fair Value Estimate
Based on comprehensive analysis
$47.94
-26.1% below current price
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Overall
47
Moderate
40
55
65
75
0
AI Verdict
cautious
Key drivers: Strong Piotroski F-Score and low leverage support financial health, Significant insider selling and declining earnings growth erode confidence, Valuation at 37.26x P/E far exceeds Graham and intrinsic value benchmarks, Analyst targets below current price indicate downside bias, Recent earnings misses and negative EPS growth contradict historical momentum
Confidence
85%
Value
40/100
Ref P/E, PEG, Graham Number
Positives
- Graham Number of $29.40 provides a defensive floor
- Intrinsic value estimate of $47.94 suggests potential undervaluation if growth stabilizes
Watchpoints
- Current price of $64.84 is 35% above intrinsic value and 120% above Graham Number
- P/E of 37.26 is elevated relative to sector average (80.43) and historical norms
- No PEG ratio available, but high P/E with slowing earnings growth implies premium pricing
Future
55/100
Ref Growth rates
Positives
- 32% YoY revenue growth indicates strong market demand
- Historical ability to beat earnings estimates (e.g., +246.2% surprise in 2023 Q1) suggests upside potential
Watchpoints
- Earnings growth has slowed to 13.7% YoY and turned negative in recent quarters (-42.9% YoY EPS)
- Q/Q EPS growth is -18.2%, signaling weakening momentum
- Forward P/E of 32.31 is still high despite declining earnings trend
Past
65/100
Ref Historical trends
Positives
- Consistent history of earnings beat rates (e.g., 10+ consecutive quarters with positive surprises)
- Strong revenue and earnings progression from 2020–2023, including multiple +50%+ EPS surprises
Watchpoints
- Recent 4-quarter beat rate is only 1/4, indicating recent underperformance
- Average earnings surprise over last 4 quarters is -6.78%, signaling weakening execution
- Last two quarters saw significant misses (e.g., -32.4% surprise in Q3 2025)
Health
75/100
Ref Altman Z-Score, Piotroski F-Score
Positives
- Piotroski F-Score of 7/9 reflects strong financial health and operational efficiency
- Low debt/equity (0.16) and high liquidity (current ratio 3.48) indicate minimal financial risk
- Positive operating and gross margins show sustainable business model
Watchpoints
- No Altman Z-Score provided, which is a critical gap for assessing bankruptcy risk
- Absence of Altman Z-Score prevents formal distress risk evaluation despite strong balance sheet
Dividend
0/100
Ref Yield, Payout
Positives
No standout positives identified.
Watchpoints
- No dividend yield or payout ratio (0.00%)
- Zero dividend strength score (0/100) reflects no shareholder return
- No history of dividend payments limits appeal to income-focused investors
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Current Price
$64.84
Analyst Target
$46.45
Upside/Downside
-28.4%
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for ACMR and closest competitors.
Updated 2026-02-13
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
ACMR
ACM Research, Inc.
Primary
|
+39.0% | +366.8% | +179.5% | +159.2% | +28.4% | +3.8% |
|
AVT
Avnet, Inc.
Peer
|
+47.0% | +23.1% | -3.7% | -3.7% | +3.3% | +0.0% |
|
ACIW
ACI Worldwide, Inc.
Peer
|
-4.3% | +47.5% | -24.7% | -15.0% | -13.0% | -6.4% |
|
BDC
Belden Inc.
Peer
|
+142.3% | +46.6% | -4.7% | -10.3% | -2.7% | -0.7% |
|
ENPH
Enphase Energy, Inc.
Peer
|
-82.6% | -86.1% | -44.9% | -11.6% | +10.7% | -0.7% |
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Historical data shows last 12 quarters (3 years)
Valuation Metrics
Key valuation ratios and pricing indicators
P/E Ratio
37.26
Forward P/E
32.31
PEG Ratio
N/A
P/B Ratio
2.94
P/S Ratio
4.78
EV/Revenue
4.35
EV/EBITDA
26.62
Market Cap
$4.21B
Profitability
Profit margins and return metrics
Profit Margin
13.3%
Operating Margin
10.75%
Gross Margin
46.68%
ROE
9.94%
ROA
3.57%
Growth
Revenue and earnings growth rates
Revenue Growth
+32.0%
Earnings Growth
+13.7%
Q/Q Revenue Growth
N/A
Q/Q Earnings Growth
+16.1%
Financial Health
Balance sheet strength and liquidity metrics
Debt/Equity
0.16
Low debt
Current Ratio
3.48
Strong
Quick Ratio
2.44
Excellent
Cash/Share
$17.41
Quarterly Earnings History
EPS performance vs analyst estimates
2026-02-26
$N/A
2025-11-05
$0.36
-32.4% surprise
2025-08-06
$0.44
-4.4% surprise
2025-05-07
$0.3
+16.5% surprise
Technology Sector Comparison
Comparing ACMR against 149 companies in the Technology sector
(11 bullish, 68 neutral, 70 bearish)
P/E Ratio
37.26
This Stock
vs
80.48
Sector Avg
-53.7%
(Discount)
Return on Equity (ROE)
9.94%
This Stock
vs
-6.46%
Sector Avg
-253.8%
(Below Avg)
Profit Margin
13.3%
This Stock
vs
-9.27%
Sector Avg
-243.6%
(Weaker)
Debt to Equity
0.16
This Stock
vs
0.7
Sector Avg
-77.4%
(Less Debt)
Revenue Growth
32.0%
This Stock
vs
61.63%
Sector Avg
-48.1%
(Slower)
Current Ratio
3.48
This Stock
vs
3.39
Sector Avg
+2.5%
(Better)
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
ACMR
ACM Research, Inc.
|
BEARISH | $4.21B | 37.26 | 9.9% | 13.3% | $64.84 | |
|
AVT
Avnet, Inc.
|
NEUTRAL | $4.13B | 18.97 | 4.7% | 1.0% | $50.83 | |
|
ACIW
ACI Worldwide, Inc.
|
NEUTRAL | $4.08B | 15.89 | 18.6% | 15.1% | $39.56 | |
|
BDC
Belden Inc.
|
NEUTRAL | $4.57B | 21.07 | 18.4% | 8.6% | $115.26 | |
|
ENPH
Enphase Energy, Inc.
|
BEARISH | $4.58B | 23.96 | 20.3% | 12.9% | $34.98 |
Recent Insider Trading
Insider buy and sell transactions from the last 6 months
| Date | Insider | Position | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-08 | MCKECHNIE MARK A | Chief Financial Officer | Sale | 31,250 | $1,091,507 |
| 2025-12-08 | MCKECHNIE MARK A | Chief Financial Officer | Option Exercise | 31,250 | $612,438 |
| 2025-12-04 | WANG DAVID HUI | Chief Executive Officer | Sale | 130,000 | $4,361,477 |
| 2025-12-04 | WANG DAVID HUI | Chief Executive Officer | Option Exercise | 130,000 | $130,000 |
| 2025-12-03 | CHEN FUPING | Officer | Sale | 120,000 | $3,981,156 |
| 2025-12-03 | CHEN FUPING | Officer | Option Exercise | 120,000 | $212,400 |
| 2025-11-13 | FENG LISA YI LU | Officer | Sale | 30,000 | $997,950 |
| 2025-11-13 | FENG LISA YI LU | Officer | Option Exercise | 30,000 | $168,000 |
| 2025-11-12 | DUN HAIPING | Director | Gift | 755,090 | - |
| 2025-09-18 | CHEAV SOTHEARA | Officer | Sale | 10,000 | $350,000 |
| 2025-09-18 | CHEAV SOTHEARA | Officer | Option Exercise | 10,000 | $138,900 |
| 2025-09-18 | WANG JIAN | Officer | Sale | 30,000 | $1,050,000 |
| 2025-09-18 | WANG JIAN | Officer | Option Exercise | 30,000 | $168,000 |
| 2025-09-17 | LIU TRACY DONG CPA | Director | Sale | 15,000 | $495,000 |
| 2025-09-17 | LIU TRACY DONG CPA | Director | Option Exercise | 15,000 | $15,000 |
Insider transactions can signal confidence or concerns about company prospects
Wall Street Analysts
Professional analyst ratings and price targets
Consensus
BUY
6 analysts
Roth Capital
2025-09-30
Buy
Buy
Past News Coverage
Recent headlines mentioning ACMR from our newsroom.
Newest → oldest
No matching news yet.